These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27362350)

  • 1. Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
    Warris LT; van den Akker EL; Bierings MB; van den Bos C; Zwaan CM; Sassen SD; Tissing WJ; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    PLoS One; 2016; 11(6):e0158225. PubMed ID: 27362350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
    Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
    Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
    Warris LT; van den Akker ELT; Bierings MB; van den Bos C; Aarsen FK; Zwaan MC; Tissing WJE; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
    Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.
    Esbenshade AJ; Simmons JH; Koyama T; Lindell RB; Friedman DL
    Pediatr Blood Cancer; 2013 Aug; 60(8):1287-91. PubMed ID: 23444342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
    Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
    J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study.
    Verwaaijen EJ; van Hulst AM; Hartman A; Pieters R; Fiocco M; Pluijm SMF; van Litsenburg RRL; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
    Cancer Med; 2023 Dec; 12(24):22304-22315. PubMed ID: 38069550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease.
    Trimis G; Moschovi M; Papassotiriou I; Chrousos G; Tzortzatou-Stathopoulou F
    J Pediatr Hematol Oncol; 2007 May; 29(5):309-14. PubMed ID: 17483708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of Metabolic Syndrome and Serum Osteopontin Levels in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Özdemir ZC; Düzenli Kar Y; Demiral M; Sırmagül B; Bör Ö; Kırel B
    J Adolesc Young Adult Oncol; 2018 Aug; 7(4):480-487. PubMed ID: 29641359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
    Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
    Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance.
    Karakurt H; Sarper N; Kılıç SÇ; Gelen SA; Zengin E
    Pediatr Hematol Oncol; 2012 Sep; 29(6):551-61. PubMed ID: 22897748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
    Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
    PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia.
    Aldhafiri F; Al-Nasser A; Al-Sugair A; Al-Mutairi H; Young D; Reilly JJ
    Pediatr Blood Cancer; 2012 Jul; 59(1):133-7. PubMed ID: 22162511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
    Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
    Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.